146 related articles for article (PubMed ID: 11720685)
1. Sentinel node imaging and biopsy in breast cancer patients.
Donahue EJ
Am J Surg; 2001 Oct; 182(4):426-8. PubMed ID: 11720685
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
Kern KA
J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589
[TBL] [Abstract][Full Text] [Related]
3. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
4. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.
Layeeque R; Kepple J; Henry-Tillman RS; Adkins L; Kass R; Colvert M; Gibson R; Mancino A; Korourian S; Klimberg VS
Ann Surg; 2004 Jun; 239(6):841-5; discussion 845-8. PubMed ID: 15166963
[TBL] [Abstract][Full Text] [Related]
6. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
[TBL] [Abstract][Full Text] [Related]
7. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of immediate preoperative injection of radiopharmaceutical and blue dye for sentinel node biopsy in patients with breast cancer.
Dixon JM; Mak C; Radhakrishna S; Kehoe T; Millar AM; Wong D; Thomas JS
Eur J Cancer; 2009 Mar; 45(5):795-9. PubMed ID: 19101140
[TBL] [Abstract][Full Text] [Related]
9. Improved lymphatic mapping technique for breast cancer.
Beitsch PD; Clifford E; Whitworth P; Abarca A
Breast J; 2001; 7(4):219-23. PubMed ID: 11678798
[TBL] [Abstract][Full Text] [Related]
10. A further validation of subareolar injection technique for breast sentinel lymph node biopsy.
D'Eredita G; Giardina C; Guerrieri AM; Berardi T
Ann Surg Oncol; 2006 May; 13(5):701-7. PubMed ID: 16523366
[TBL] [Abstract][Full Text] [Related]
11. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
12. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer.
D'Eredita' G; Ferrarese F; Cecere V; Massa ST; de Carne F; Fabiano G
Ann Surg Oncol; 2003 Oct; 10(8):942-7. PubMed ID: 14527915
[TBL] [Abstract][Full Text] [Related]
13. Combination of subareolar blue dye and peritumoral RI for sentinel lymph node biopsy.
Tsunoda N; Iwata H; Sarumaru S; Mizutani M; Iwase T; Miura S
Breast Cancer; 2002; 9(4):323-8. PubMed ID: 12459714
[TBL] [Abstract][Full Text] [Related]
14. Subareolar versus peritumoral injection for location of the sentinel lymph node.
Klimberg VS; Rubio IT; Henry R; Cowan C; Colvert M; Korourian S
Ann Surg; 1999 Jun; 229(6):860-4; discussion 864-5. PubMed ID: 10363900
[TBL] [Abstract][Full Text] [Related]
15. Intraoperative injection of subareolar or dermal radioisotope results in predictable identification of sentinel lymph nodes in breast cancer.
Johnson CB; Boneti C; Korourian S; Adkins L; Klimberg VS
Ann Surg; 2011 Oct; 254(4):612-8. PubMed ID: 21918427
[TBL] [Abstract][Full Text] [Related]
16. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer.
Bauer TW; Spitz FR; Callans LS; Alavi A; Mick R; Weinstein SP; Bedrosian I; Fraker DL; Bauer TL; Czerniecki BJ
Ann Surg Oncol; 2002 Mar; 9(2):169-76. PubMed ID: 11888875
[TBL] [Abstract][Full Text] [Related]
17. Subareolar injection of 99mTc facilitates sentinel lymph node identification.
Tuttle TM; Colbert M; Christensen R; Ose KJ; Jones T; Wetherille R; Friedman J; Swenson K; McMasters KM
Ann Surg Oncol; 2002; 9(1):77-81. PubMed ID: 11829434
[TBL] [Abstract][Full Text] [Related]
18. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
